6-substituted pyrazolo[3,4-D]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors

Details for Australian Patent Application No. 2002255614 (hide)

Owner BRISTOL-MYERS SQUIBB PHARMA COMPANY

Inventors Markwalder, Jay, A.; Sherk, Susan, R.; Seitz, Steven, P.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2002255614

PCT Pub. Number WO2002/067654

Priority 09/794,825 27.02.01 US

Filing date 27 February 2002

Wipo publication date 12 September 2002

Event Publications

6 March 2003 Application Open to Public Inspection

  Published as AU-A-2002255614

24 March 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002255615-PROCEDURES AND APPARATUS FOR TURNING-ON AND TURNINGOFF ELEMENTS WITHIN A FED DEVICE

2002255613-NOVEL MATRIX METALLOPROTEASE INHIBITORS